• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
25.0% 0.3¢

ALTERITY THERAPEUTICS LIMITED - Discussion

Market Cap $15.96M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Alterity Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 3 26/07/24
26/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 3 26/07/24
26/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 26/07/24
26/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 6 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 3 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Mateo335 169 49K 2 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 5 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 6 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 11 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 11
ASX - By Stock ATH Re: Ann: Alterity Therapeutics to Present at MST Financial Webinar Thread Scottsmyname 3 1.3K 1 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Alterity Therapeutics to Present at MST Financial Webinar Thread Scottsmyname 3 1.3K 3 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 3 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread brryh 169 49K 3 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread skint 169 49K 1 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread skint 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
Metals & Mining SECTOR NEWS

Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity

CC9
03 Oct 2024
CHARIOT CORPORATION LTD
Read More   right-arrow Created with Sketch.
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread brryh 169 49K 4 25/07/24
25/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread skint 169 49K 6 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread RebekahChambers 169 49K 2 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Alterity Therapeutics to Present at MST Financial Webinar Thread Scottsmyname 3 1.3K 1 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread RebekahChambers 169 49K 3 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Ann: Alterity Therapeutics to Present at MST Financial Webinar Thread ASX News 3 1.3K 13 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 13
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread skint 169 49K 8 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Good to look at the reference study by Wenning et al Thread Mateo335 8 2.6K 5 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 8 Views Created with Sketch. 2.6K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Good to look at the reference study by Wenning et al Thread grenade001 8 2.6K 4 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 8 Views Created with Sketch. 2.6K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Good to look at the reference study by Wenning et al Thread pivalde 8 2.6K 10 24/07/24
24/07/24 ASX - By Stock Thread Comments Created with Sketch. 8 Views Created with Sketch. 2.6K Likes Created with Sketch. 10
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 3 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Sentisure 169 49K 2 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread MrLearner 169 49K 2 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 7 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 7
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Gordon2020 169 49K 1 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Gordon2020 169 49K 5 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread #lancearmstrong 169 49K 5 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 0 23/07/24
23/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Sentisure 169 49K 8 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread groins 169 49K 1 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread amb005 169 49K 4 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread singhgu 169 49K 1 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread amb005 169 49K 5 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 22/07/24
22/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Notice Under Section 708A Thread Gordon2020 2 1.0K 4 20/07/24
20/07/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.0K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Value of company post Positive phase 2 trial results Thread Gordon2020 5 2.2K 6 20/07/24
20/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Value of company post Positive phase 2 trial results Thread MrLearner 5 2.2K 0 20/07/24
20/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Notice Under Section 708A Thread Domy 2 1.0K 2 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.0K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Value of company post Positive phase 2 trial results Thread Scottsmyname 5 2.2K 1 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Value of company post Positive phase 2 trial results Thread ironlung 5 2.2K 12 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 12
ASX - By Stock ATH Re: Value of company post Positive phase 2 trial results Thread Sentisure 5 2.2K 6 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 6
ASX - By Stock ATH Ann: Notice Under Section 708A Thread ASX News 2 1.0K 1 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.0K Likes Created with Sketch. 1
ASX - By Stock ATH Ann: Application for quotation of securities - ATH Thread ASX News 0 358 1 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 358 Likes Created with Sketch. 1
ASX - By Stock ATH Value of company post Positive phase 2 trial results Thread pierre77 5 2.2K 3 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.2K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 3 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Gordon2020 169 49K 6 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread ZF777 169 49K 6 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Stockman 169 49K 11 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 11
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 1 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Good to look at the reference study by Wenning et al Thread pivalde 8 2.6K 6 19/07/24
19/07/24 ASX - By Stock Thread Comments Created with Sketch. 8 Views Created with Sketch. 2.6K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Good to look at the reference study by Wenning et al Thread pivalde 8 2.6K 8 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 8 Views Created with Sketch. 2.6K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 4 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread immy101 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Kyriaco 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Proposed issue of securities - ATH Thread pivalde 1 743 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 1 Views Created with Sketch. 743 Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread valueadd 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread BoZz 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 4 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread amb005 169 49K 5 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread free2nap 169 49K 4 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Scottsmyname 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 0 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread FiveCent 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread flashharry 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Stockman 169 49K 10 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 10
ASX - By Stock ATH Ann: Proposed issue of securities - ATH Thread ASX News 1 743 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 1 Views Created with Sketch. 743 Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread FiveCent 169 49K 2 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Mateo335 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread rakeshnirzari1 169 49K 0 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread IronPig 169 49K 6 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread chucke 169 49K 4 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Mateo335 169 49K 13 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 13
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread groins 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread Cuprum29 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread ZF777 169 49K 1 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread lovethespeccies 169 49K 4 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial Thread amb005 169 49K 3 18/07/24
18/07/24 ASX - By Stock Thread Comments Created with Sketch. 169 Views Created with Sketch. 49K Likes Created with Sketch. 3
refresh Created with Sketch. REFRESH

Featured News

NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
NEWS New multi-lode gold shoot discovery boosts development potential—find out who's behind this
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
(20min delay)
Last
0.3¢ 		Change
-0.001(25.0%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $32.63K 10.83M

Buyers (Bids)

No. Vol. Price($)
28 21801548 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130971725 28
View Market Depth
Last trade - 16.10pm 03/10/2024 (20 minute delay) ?
Last
0.3¢ 		  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.3¢ 0.4¢ 0.3¢ 16250578
Last updated 14.49pm 03/10/2024 ?
ATH (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Firefly positioned for copper growth in Canada ahead of resource update Firefly Metals Ltd has reported drilling reports from its Green Bay copper-gold project in Newfoundland, ahead of a resource update
Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20% Chariot has unveiled its vision for its US-based Black Mountain – aiming to fast-track its path to production by establishing a "pilot mine."
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.

Featured News

NEWS Eagles Nest drilling confirms high-grade gold with shallow mineralisation expanding, delivering multiple strong intersections
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.